Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
ACS Chemical Neuroscience
|
September 1, 2016
Mutagenesis Analysis Reveals Distinct Amino Acids of the Human Serotonin 5-HT<sub>2C</sub> Receptor Underlying the Pharmacology of Distinct Ligands
Yue Liu, Clinton E Canal, Tania C Cordova-Sintjago, et al.
Journal of Neurochemistry
|
January 22, 2009
RNA editing of the serotonin 2C receptor and expression of Galpha(q) protein: genetic mouse models do not support a role for regulation or compensation
Clinton E Canal, Kontip C Mahautmr, Chike Cao, et al.
ACS Chemical Neuroscience
|
December 6, 2022
FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult <i>Fmr1</i> Knockout Mice
Tanishka S Saraf, Ryan P McGlynn, Omkar M Bhatavdekar, et al.
Epilepsy Research
|
June 15, 2021
Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice
Tanishka S Saraf, Daniel E Felsing, Jessica L Armstrong, et al.
European Journal of Pharmacology
|
October 25, 2011
Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation
Clinton E Canal, Tania C Cordova-Sintjago, Nancy Y Villa, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 2, 2013
Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands
Clinton E Canal, Tania Cordova-Sintjago, Yue Liu, et al.
ACS Pharmacology & Translational Science
|
June 23, 2020
(<i>S</i>)-5-(2'-Fluorophenyl)-<i>N</i>,<i>N</i>-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an <i>Fmr1</i> Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder
Jessica L Armstrong, Austen B Casey, Tanishka S Saraf, et al.
Psychopharmacology
|
October 3, 2018
Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice
Azizi Ray, Neha Milind Chitre, Cedrick Maceo Daphney, et al.
Frontiers in Neuroscience
|
June 29, 2010
Impact of RNA editing on functions of the serotonin 2C receptor in vivo
Uade B Olaghere da Silva, Michael V Morabito, Clinton E Canal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 25, 2014
A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses
Clinton E Canal, Drake Morgan, Daniel Felsing, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
ACS Chemical Neuroscience
|
September 1, 2016
Mutagenesis Analysis Reveals Distinct Amino Acids of the Human Serotonin 5-HT<sub>2C</sub> Receptor Underlying the Pharmacology of Distinct Ligands
Yue Liu, Clinton E Canal, Tania C Cordova-Sintjago, et al.
Journal of Neurochemistry
|
January 22, 2009
RNA editing of the serotonin 2C receptor and expression of Galpha(q) protein: genetic mouse models do not support a role for regulation or compensation
Clinton E Canal, Kontip C Mahautmr, Chike Cao, et al.
ACS Chemical Neuroscience
|
December 6, 2022
FPT, a 2-Aminotetralin, Is a Potent Serotonin 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, and 5-HT<sub>1D</sub> Receptor Agonist That Modulates Cortical Electroencephalogram Activity in Adult <i>Fmr1</i> Knockout Mice
Tanishka S Saraf, Ryan P McGlynn, Omkar M Bhatavdekar, et al.
Epilepsy Research
|
June 15, 2021
Evaluation of lorcaserin as an anticonvulsant in juvenile Fmr1 knockout mice
Tanishka S Saraf, Daniel E Felsing, Jessica L Armstrong, et al.
European Journal of Pharmacology
|
October 25, 2011
Drug discovery targeting human 5-HT(2C) receptors: residues S3.36 and Y7.43 impact ligand-binding pocket structure via hydrogen bond formation
Clinton E Canal, Tania C Cordova-Sintjago, Nancy Y Villa, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 2, 2013
Molecular pharmacology and ligand docking studies reveal a single amino acid difference between mouse and human serotonin 5-HT2A receptors that impacts behavioral translation of novel 4-phenyl-2-dimethylaminotetralin ligands
Clinton E Canal, Tania Cordova-Sintjago, Yue Liu, et al.
ACS Pharmacology & Translational Science
|
June 23, 2020
(<i>S</i>)-5-(2'-Fluorophenyl)-<i>N</i>,<i>N</i>-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an <i>Fmr1</i> Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder
Jessica L Armstrong, Austen B Casey, Tanishka S Saraf, et al.
Psychopharmacology
|
October 3, 2018
Effects of the second-generation "bath salt" cathinone alpha-pyrrolidinopropiophenone (α-PPP) on behavior and monoamine neurochemistry in male mice
Azizi Ray, Neha Milind Chitre, Cedrick Maceo Daphney, et al.
Frontiers in Neuroscience
|
June 29, 2010
Impact of RNA editing on functions of the serotonin 2C receptor in vivo
Uade B Olaghere da Silva, Michael V Morabito, Clinton E Canal, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 25, 2014
A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses
Clinton E Canal, Drake Morgan, Daniel Felsing, et al.
Page
of 4